Covered recipient · General Payments record
ANDREW SHAW
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$4,334.56
- Reported across 210 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,356.56 | 61 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $147.99 | 7 |
| Acerta Pharma LLC | $141.71 | 5 |
| E.R. Squibb & Sons, L.L.C. | $86.62 | 3 |
| PFIZER INC. | $83.52 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $80.88 | 3 |
| Merck Sharp & Dohme Corporation | $74.45 | 4 |
| Astellas Pharma US Inc | $63.22 | 3 |
| JAZZ PHARMACEUTICALS INC. | $58.57 | 2 |
| Daiichi Sankyo Inc. | $55.15 | 3 |
| Incyte Corporation | $48.29 | 2 |
| ABBVIE INC. | $47.72 | 2 |
| Stemline Therapeutics Inc. | $45.22 | 2 |
| Celgene Corporation | $41.78 | 2 |
| Ipsen Biopharmaceuticals, Inc | $40.16 | 2 |
| EISAI INC. | $39.87 | 2 |
| Agios Pharmaceuticals, Inc. | $39.23 | 2 |
| Genentech USA, Inc. | $33.15 | 2 |
| ARRAY BIOPHARMA INC | $26.96 | 1 |
| Genmab U.S., Inc. | $26.53 | 1 |
| SERVIER PHARMACEUTICALS LLC | $23.46 | 1 |
| Sumitomo Pharma America, Inc. | $23.26 | 1 |
| Gilead Sciences, Inc. | $21.11 | 1 |
| SOBI, INC | $20.68 | 1 |
| ADC THERAPEUTICS AMERICA, INC. | $20.31 | 1 |
| Karyopharm Therapeutics Inc. | $18.58 | 1 |
| SpringWorks Therapeutics, Inc. | $17.93 | 1 |
| Janssen Biotech, Inc. | $16.45 | 1 |
| Lilly USA, LLC | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (61)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.